z-logo
open-access-imgOpen Access
Rational development and characterization of humanized anti–EGFR variant III chimeric antigen receptor T cells for glioblastoma
Author(s) -
Laura A. Johnson,
John Scholler,
Takayuki Ohkuri,
Akemi Kosaka,
Prachi Patel,
Shan E. McGettigan,
Arben Nace,
Tzvete Dentchev,
Pramod Thekkat,
Andreas Loew,
Alina C. Boesteanu,
Alexandria P. Cogdill,
Taylor Chen,
Joseph A. Fraietta,
Christopher C. Kloss,
Avery D. Posey,
Boris Engels,
Reshma Singh,
Tucker Ezell,
Neeraja Idamakanti,
Melissa Ramones,
Na Li,
Li Zhou,
Gabriela Plesa,
John T. Seykora,
Hideho Okada,
Carl H. June,
Jennifer L. Brogdon,
Marcela V. Maus
Publication year - 2015
Publication title -
science translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.819
H-Index - 216
eISSN - 1946-6242
pISSN - 1946-6234
DOI - 10.1126/scitranslmed.aaa4963
Subject(s) - chimeric antigen receptor , glioblastoma , antigen , cancer research , receptor , medicine , immunology , chemistry , immunotherapy , immune system

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom